Rate My Professor Mariam Molokhia

Professor Mariam Molokhia is a clinical epidemiologist and General Practitioner qualified with MBChB and PhD, serving as Professor of Clinical Epidemiology and Primary Care in the Department of Population Health Sciences, School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine at King's College London. Her career encompasses expertise in pharmacoepidemiology, pharmacogenetics, and genetic epidemiology of complex traits, with a focus on ethnic differences in disease risk, primary care research, health inequalities, cardiovascular disease, chronic kidney disease, diabetes, metabolic health, multimorbidity, and adverse drug reactions. She employs routine health records from databases including CPRD, THIN, Lambeth DataNet, and OneLondon, alongside prescribing data and pharmacogenomics. Molokhia coordinates international collaborations such as the EUDRAGENE project on genetic susceptibility to adverse drug reactions and contributes to EU-funded initiatives like EU-ADR and ARITMO on drug safety. Her research informs policy and practice, including NHS Health Check reforms, European Society for Cardiology guidelines on anticoagulation, and genomic testing implementation in primary care.

Mariam Molokhia leads multidisciplinary programs for underserved and ethnically diverse communities, spanning observational studies, intervention development, implementation science, and innovative community-based care models. Key projects include the BELONG Study evaluating hairdressers promoting culturally adapted online tools for detecting hypertension and diabetes; the NHS Race and Health Observatory study on familial hypercholesterolemia identification across ethnic groups; and an NIHR HSDR study enhancing kidney failure risk prediction with tailored educational materials and policy recommendations. She has delivered an inaugural lecture titled 'A Journey through Health Inequalities' and supervises PhD students while teaching undergraduate MBBS, iBSc in Primary Care, and postgraduate MPH modules in global public health. Notable publications comprise 'HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans' (New England Journal of Medicine, 2011), 'Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles' (Gastroenterology, 2011), and 'Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: Retrospective cohort study using UK general practice research database' (BMJ, 2009).